SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-003213
Filing Date
2023-05-11
Accepted
2023-05-11 17:01:09
Documents
50
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q phio_i10q-033123.htm   iXBRL 10-Q 485394
2 CERTIFICATION phio_ex3101.htm EX-31.1 10234
3 CERTIFICATION phio_ex3201.htm EX-32.1 4114
  Complete submission text file 0001683168-23-003213.txt   3021899

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE phio-20230331.xsd EX-101.SCH 25083
5 XBRL CALCULATION FILE phio-20230331_cal.xml EX-101.CAL 34354
6 XBRL DEFINITION FILE phio-20230331_def.xml EX-101.DEF 106760
7 XBRL LABEL FILE phio-20230331_lab.xml EX-101.LAB 221598
8 XBRL PRESENTATION FILE phio-20230331_pre.xml EX-101.PRE 181663
44 EXTRACTED XBRL INSTANCE DOCUMENT phio_i10q-033123_htm.xml XML 398275
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 23912014
SIC: 2834 Pharmaceutical Preparations